Valar Labs Publishes Pivotal Study in Journal of Clinical Oncology Validating AI to Predict Chemotherapy Response for Pancreatic Cancer Patients

Valar Labs is a precision oncology company using artificial intelligence to reduce the uncertainty in cancer treatment. By analyzing standard pathology slides, Valar's AI biomarkers predict response ...
Fred Hutch

Clinical Cancer Genomics Laboratory

Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
Hosted on MSN

Europe plans first space-based cancer lab to study tumors beyond Earth’s gravity

Europe is preparing to take cancer research beyond Earth. At Frontiers Science House in Davos, SPARK Microgravity GmbH revealed plans to build Europe’s first dedicated commercial orbital cancer ...
Seeking Alpha

Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab Limited (ZLAB) (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has accepted the ...